Company: ARBK
Filing Date: 2025-05-09
Form Type: 6-K
Source: 0001654954-25-005344
Chunk: 22

Company: Argo Blockchain Plc
Filing Date: 2025-05-09
Form: 6-K
Chunk 22
---
 of 6.12%.

UK 10-year CEO table and UK percentage change table

The directors have considered the requirement for a UK 10-year CEO table and UK percentage change table. The directors do not currently consider that including these tables would be meaningful because, the CEO remuneration is not currently linked to performance, therefore any comparison across years or with the employee group would be significantly skewed and would not add any information of value to shareholders. The CEO’s remuneration is disclosed in full in the directors’ remuneration section. The directors will review the inclusion of this table for future reports.

Relative importance of spend on pay

The directors have considered the requirement to present information on the relative importance of spend on pay compared to shareholder dividends paid. Given that the Company does not currently pay dividends this would not provide meaningful disclosure to shareholders.

Consideration of shareholder views

At the present time, the Company does not have any significant institutional shareholder base, or any significant shareholders with which to proactively consult. Therefore, the Board considers shareholder feedback received in the context of annual general meetings and applicable guidance from shareholder bodies. This feedback, plus any additional feedback received from time to time, is considered as part of the Group’s annual policy on remuneration.

Policy for new appointments

Base salary levels will take into account market data for the relevant role, internal relativities, the individual’s experience and their current base salary. Where an individual is recruited at below market norms, they may be re- aligned over time (e.g. two to three years), subject to performance in the role. Benefits will generally be in accordance with the approved policy.

For external and internal appointments, the Board may agree that the Group will meet certain relocation and/or incidental expenses as appropriate.

Other matters

The Company does not currently have any annual or long-term incentive schemes in place for any of the directors and as such there are no disclosures in this respect. The share options granted are discussed above.

Raghav Chopra

Chair of the Remuneration Committee

8 May 2025

### NOMINATION COMMITTEE REPORT
Letter from the Chair of the Nomination Committee

Dear Shareholders,

I am pleased to present the Nomination Committee’s report for the year ended 31 December 2024.

The Nomination Committee met twice during the financial year under review, and all of the directors on the Committee attended both meetings. At a high level, its role is to:

●

draw up selection criteria and appointment procedures for board members;

●

recommend nominees